EFL

Cohort Year: 2023-2024

Tracks: Life Sciences

VISIT WEBSITE

IMNEWRUN

IMNEWRUN is developing a novel blood-brain barrier penetrating antibody platform and therapeutic pipeline for patients with brain-related diseases, starting with Alzheimer's disease.